Peer Review reports
From: NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway
| Original Submission | ||
|---|---|---|
| 17 Jan 2021 | Submitted | Original manuscript |
| 15 Mar 2021 | Reviewed | Reviewer Report |
| 17 Mar 2021 | Reviewed | Reviewer Report |
| 23 Mar 2021 | Reviewed | Reviewer Report |
| 8 May 2021 | Author responded | Author comments - Huailin Wang |
| Resubmission - Version 2 | ||
| 8 May 2021 | Submitted | Manuscript version 2 |
| 6 Jun 2021 | Reviewed | Reviewer Report |
| 7 Jun 2021 | Reviewed | Reviewer Report |
| 8 Jun 2021 | Reviewed | Reviewer Report |
| 15 Jun 2021 | Author responded | Author comments - Huailin Wang |
| Resubmission - Version 3 | ||
| 15 Jun 2021 | Submitted | Manuscript version 3 |
| 28 Jun 2021 | Author responded | Author comments - Huailin Wang |
| Resubmission - Version 4 | ||
| 28 Jun 2021 | Submitted | Manuscript version 4 |
| Publishing | ||
| 6 Jul 2021 | Editorially accepted | |
| 30 Jul 2021 | Article published | 10.1186/s12885-021-08597-8 |
You can find further information about peer review here.